CDH1 and neoplasm: While our integrated bioinformatics approach identified miR-34a-5p/CDH1 as a putative regulatory axis, we acknowledge the paradoxical upregulation of CDH1 (a canonical tumor suppressor) in prostate adenocarcinoma.